| Course | NS460 Dietary Supplements and Nutraceuticals |
|---|---|
| Unit | Unit 9 |
| Paper type | Systematic review summary |
| Length | About 860 words, 6 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Nutrition Science |
| Updated | October 2026 |
Free sample paper for NS460 Unit 9
Same Question, Opposite Answers: A Unit 9 Systematic Review Summary of Cranberry for Preventing Urinary Tract Infections
[Student Name]
Purdue University Global
NS460: Dietary Supplements and Nutraceuticals
Unit 9 Systematic Review Summary
[Instructor Name]
[Date]
The summary is the student's own; the two Cochrane reviews and the GRADE paper cited are real.
The Question
Do cranberry products, such as juice, tablets or capsules, prevent urinary tract infections compared with placebo, water or no treatment? Cranberry has long been recommended for this purpose, and both reviews summarized here were produced by the Cochrane Kidney and Transplant group with overlapping authors.
The 2012 Review
The 2012 update included 24 studies with 4,473 participants (Jepson et al., 2012). Compared with placebo, water or no treatment, cranberry products did not significantly reduce symptomatic urinary tract infections overall, with a risk ratio of 0.86 and a confidence interval crossing 1. No subgroup, including women with recurrent infections, children, older adults or pregnant women, showed a significant benefit. The authors noted that many participants dropped out, especially in juice trials, and concluded that cranberry juice could not be recommended for prevention.
The 2023 Review
The 2023 update added 26 new studies, bringing the total to 50 studies with 8,857 participants (Williams et al., 2023). Twenty-six studies with 6,211 participants could be pooled for symptomatic, culture-verified infections. Cranberry products reduced the risk by about 30 percent, a risk ratio of 0.70, and the authors rated the certainty as moderate.
The benefit differed by group.
1. Women with recurrent infections: risk ratio 0.74, moderate certainty.
2. Children: risk ratio 0.46, moderate certainty.
3. People susceptible because of a medical procedure: risk ratio 0.47, moderate certainty.
4. Elderly people in care facilities: little or no benefit.
5. Pregnant women and people with bladder-emptying problems: little or no benefit, low certainty.
The reversal came mainly from more and better trials, which turned an uncertain small effect in 2012 into a moderate-certainty benefit for specific groups in 2023.
Why the Conclusion Changed
Three differences explain most of the change. First, the number of participants nearly doubled, which narrowed the confidence intervals; the 2012 estimate for women with recurrent infections was the same risk ratio of 0.74, but with an interval that crossed 1. Second, the newer studies were more often at low risk of bias, and more measured infections confirmed by urine culture rather than symptoms alone. Third, the 2023 review grouped participants by why they were at risk, which separated groups that benefit from groups that do not. Pooling everyone together, as earlier analyses effectively did, diluted the effect.
Certainty and Its Meaning
The review used GRADE, which rates how confident reviewers are that an estimate is close to the true effect (Guyatt et al., 2008). A moderate rating tells readers to expect the real benefit to sit near the pooled figure, while allowing that further trials could move it a good deal. For the overall result, certainty was reduced partly because results varied between studies more than expected by chance, with high heterogeneity.
Open Questions
One gap is that the 2023 update does not identify the best product, dose or duration, because trials used juices, tablets and capsules with different amounts of active compounds. It cannot say whether cranberry is as effective as preventive antibiotics, since too few trials compared them directly. Adverse effects were similar to placebo, although juice adds sugar and calories.
How Cranberry Might Work
Cranberries contain proanthocyanidins, plant compounds that in laboratory studies make it harder for some bacteria to stick to the lining of the bladder. That proposed mechanism helps explain why cranberry might prevent infections but would not treat one that has already started. It also suggests why the amount of these compounds in a product could matter. Many trials did not measure or report the proanthocyanidin content of the products they tested, which is one reason the review cannot recommend a specific dose.
Reading the Numbers for One Person
A risk ratio of 0.74 means that, among women with recurrent infections, those taking cranberry had about three quarters of the risk of those who did not. For a woman who would otherwise expect four infections a year, that might mean about three. The benefit is real but modest, and it depends on taking a product consistently for months. A counselor can present it that way, as one option alongside others her doctor may suggest, rather than as a cure.
Practical Summary
For women with recurrent urinary tract infections, children and people undergoing procedures that raise risk, cranberry products probably reduce the chance of a symptomatic infection by about a quarter or more. For older adults in care homes, pregnant women and people with bladder-emptying problems, they probably do little. Cranberry is a preventive option, not a treatment for an active infection, which still needs medical care.
Lesson for Reading Reviews
The cranberry reversal shows that a systematic review is a snapshot of the trials available when it was written. A 2012 conclusion that cranberry "cannot be recommended" was reasonable then and is outdated now. Anyone citing a review should check for an update before quoting its conclusion.
References
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008). GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924-926. https://doi.org/10.1136/bmj.39489.470347.AD
Jepson, R. G., Williams, G., & Craig, J. C. (2012). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews, (10), CD001321. https://doi.org/10.1002/14651858.CD001321.pub5
Williams, G., Stothart, C. I., Hahn, D., Stephens, J. H., Craig, J. C., & Hodson, E. M. (2023). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews, (11), CD001321. https://doi.org/10.1002/14651858.CD001321.pub7
What the NS460 Unit 9 assignment asks for
The ninth NS460 unit asks students to summarize a systematic review on a supplement for a professional audience. Prompts typically ask for the question, methods, main results, certainty and implications. State the review question in plain terms. Give the number of studies and participants. Report the main effect with its confidence interval and certainty rating. Break results down by population, since benefits often differ by group. If an earlier version exists, compare them and explain any change. Define the certainty rating you report. Say what the review cannot settle, such as dose or product type. Translate a relative effect into what it means for one person. Close with practical guidance and a lesson about reading reviews. Most summaries run three to four pages with clear headings.
How the NS 460 Unit 9 example is put together
The sample states the question and notes that both reviews came from the same Cochrane group. The 2012 section reports 24 studies, the nonsignificant overall result and the dropout problem. The 2023 section reports 50 studies, the pooled 0.70 risk ratio and moderate certainty, then lists results for five groups. A highlighted sentence attributes the reversal to more and better trials. A section explains three reasons for the change, including the identical 0.74 estimate that gained a narrower interval. Certainty is defined using GRADE. Open questions cover product, dose and comparison with antibiotics. A mechanism section and a worked example of the risk ratio precede the practical summary and the closing lesson on checking for updates.
Reading the NS460 Unit 9 grading rubric
Systematic review summaries are generally scored on accuracy, clarity, correct reporting of certainty and useful interpretation. The greatest weight usually falls on reporting effect sizes and certainty accurately for each population. Instructors reward summaries that explain differences between review versions rather than only reporting the latest. Defining certainty ratings in plain language shows understanding. Identifying what the review cannot answer is expected. Translating relative effects into practical terms adds value for professional readers. The conclusion should match the evidence for each group, so that a benefit found in children is never presented as a benefit for older adults in care homes. Discussing why an earlier review disagreed adds analytical credit. Clear organization and correct APA 7 references to the reviews complete the rubric.
NS460 Unit 9 help from the desk
A common problem is reporting only the overall effect and ignoring that benefit differs by group. Another is presenting a risk ratio without its confidence interval or certainty rating. Writers sometimes cite an outdated review without checking for an update. Certainty ratings are mentioned but not explained. Limitations such as product variability are skipped. Practical guidance overstates the benefit or applies it to groups where it did not hold. If you have a systematic review assigned but find the results tables hard to condense, our team can help you pull out the key effects, populations and certainty ratings.
Get an NS460 Unit 9 example written to your instructions
Which review, or which topic, did Unit 9 assign? Send that, the rubric, and the abstract format your instructor requires. Findings get reported population by population, the review's own certainty ratings attached, and nothing is pooled that the authors kept apart. A first sample costs nothing, and the turnaround is 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More NS460 papers and BS in Nutrition Science samples
- NS460 Unit 1: Biotin Gummy Discussion Post
- NS460 Unit 2: Supplement Regulatory Brief
- NS460 Unit 3: Elderberry Syrup Label Analysis
- NS460 Unit 4: Glucosamine Supplement Monograph
- NS460 Unit 5: Berberine Seminar Reflection
- NS460 Unit 6: CoQ10 Interaction Review
- NS460 Unit 7: Ashwagandha Botanical Case Study
- NS460 Unit 8: Pre-Workout Supplement Handout
- NS460 Unit 10: Final Product Review
- NS455 Unit 9: Twin Diet Trial Journal Club
- NS420 Unit 9: MITI Counseling Self-Evaluation
- NS410 Unit 9: Program Evaluation Plan
- NS325 Unit 9: Picky Toddler Meal Plan
NS460 Unit 9 questions, answered
Is a systematic review summary the same as a literature review?
No. A literature review gathers and synthesizes studies you select, while a systematic review summary reports on one review someone else has already conducted, faithfully and critically. The task is to convey its question, methods, findings and certainty accurately and to comment on its strengths and limits. Adding studies the review did not include turns the assignment into something else.
Where do I find the certainty ratings?
In Cochrane reviews they usually sit in the summary of findings table, graded with the GRADE approach as high, moderate, low or very low for each main outcome. Other reviews may report risk of bias without an overall certainty grade. If yours has them, carry the grades through; if it does not, say so and describe the risk-of-bias findings instead.
Should the summary include the effect sizes?
Include the main ones with their confidence intervals, each stated for the population it applies to. A relative risk without its population and outcome misleads more than it informs. Pair each figure with a plain translation, such as fewer confirmed infections in women with a history of recurrence, so that a reader without statistics training can follow what the number means.
Where can I find a free NS460 Unit 9 sample paper?
This page has a complete Unit 9 summary of the 2023 Cochrane review of cranberry for preventing urinary tract infections, compared with the 2012 version, with effects by group and certainty ratings.
Does cranberry prevent urinary tract infections, according to the NS460 Unit 9 sample?
In the 2023 review, cranberry products probably reduced symptomatic infections in women with recurrent infections, children and people at risk after procedures, with moderate certainty. Little or no benefit was found for care home residents.